Biomarkers clinical trials at UC Health

• Human Epilepsy Project 2: Resistant Focal Seizures Study

  Sorry, in progress, not accepting new patients

  The HEP2 study is designed to better understand the challenges of living with focal seizures that do not respond to medication, by following 205 people with medication-resistant focal epilepsy over two years to measure changes in health status, healthcare costs, quality of life, and biomarkers of epilepsy severity and treatment response.

  at UCSF

Last updated: February 1, 2021